Ati Hakimi
Family Medicine · Las Vegas, NVNPI 1881635654
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 59 payments — averaging $89.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$710
- Amgen$590
- UCB, Inc.$526
- Sanofi$369
- Regeneron Healthcare Solutions, Inc.$340
- E.r. Squibb & Sons, L.L.C.$316
- plus $2K from 17 others
What the payments were for
- Food & beverage$5,254100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 6 | $710 |
| Amgen(2 entities) | 5 | $590 |
| UCB, Inc. | 13 | $526 |
| Sanofi | 3 | $369 |
| Regeneron Healthcare Solutions, Inc. | 3 | $340 |
| E.r. Squibb & Sons, L.L.C. | 4 | $316 |
| GSK | 2 | $223 |
| Biogen | 2 | $219 |
| Johnson & Johnson | 2 | $203 |
| AbbVie | 1 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $149 |
| Akcea Therapeutics, Inc. | 1 | $142 |
| Abbott | 2 | $140 |
| Boston Scientific | 2 | $139 |
| Genentech, Inc. | 1 | $129 |
| Viiv Healthcare Company | 1 | $125 |
| AstraZeneca | 1 | $122 |
| Gilead | 1 | $122 |
| Lilly USA, LLC | 3 | $120 |
| Kyowa Kirin, Inc. | 1 | $119 |
| Amarin Pharma, Inc. | 1 | $116 |
| Novo Nordisk | 1 | $111 |
| Medtronic | 1 | $73 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,254 in reported general payments places this provider in the 90th percentile of 902 family medicine providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 11 | $267 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Las Vegas
- Naz WahabLas Vegas$563K
- Jerry CadeLas Vegas$180K
- Nilesh GokalLas Vegas$75K
- Warren MagnusLas Vegas$70K
- Kimberly AdamsLas Vegas$51K
- Mandeep GillLas Vegas$24K
- Francis JimenezLas Vegas$20K
- Ryan HuangLas Vegas$18K
- Ma Francesca ChamianLas Vegas$17K
- Leo CapobiancoLas Vegas$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.